Cure Alzheimer's Fund
Meets Standards
Standards For Charity Accountability
Governance
-
Board Oversight
-
Board Size
-
Board Meetings
-
Board Compensation
-
Conflict of Interest
Measuring Effectiveness
-
Effectiveness Policy
-
Effectiveness Report
Finances
-
Program Expenses
-
Fundraising Expenses
-
Accumulating Funds
-
Audit Report
-
Detailed Expense Breakdown
-
Accurate Expense Reporting
-
Budget Plan
Fundraising & Info
-
Truthful Materials
-
Annual Report
-
Website Disclosures
-
Donor Privacy
-
Cause Marketing Disclosures
-
Complaints
Cure Alzheimer's Fund meets the 20 Standards for Charity Accountability.
Stated Purpose:
"to fund research with the highest probability of slowing, stopping or reversing Alzheimer's disease through venture philanthropy."
Year, State Incorporated:
2004, PA
Also Known As:
Alzheimer's Disease Research Foundation
Cure Alzheimer’s Fund (CAF) provides funds to scientists throughout the world investigating the causes of Alzheimer’s disease. Discoveries include the role of genetics through the Alzheimer’s Genome Project; the positive and negative effects of lifestyle factors including exercise, diet, sleep, and air pollution; new tools that assist with evaluating potential use in treating Alzheimer’s disease with existing approved drugs; investigation into the role of beta-amyloid; and potential diagnostic measurement tools. CAF also operates larger-scale investigations within specific areas of the science. Its consortia model provides for initiatives with funding ranging from $2 million - $7 million and an expanded level of collaboration among scientists from various research institutions. This model includes Alzheimer’s Disease Drug Discovery and Development (AD4) Consortium; Fleming APOE Consortium; Brain Entry & Exit Consortium; Collaboration to Infer Regulatory Circuits and to Uncover Innovative Therapeutic Strategies (CIRCUITS) Consortium; Neuroinflammation Consortium; and Tau Consortium.
For the year ended December 31, 2022, Cure Alzheimer's Fund's program expenses were:
Research distributions and support: $24,460,315
Other program expenses: $3,426,801
Total Program Expenses: $27,887,116
Chief Executive
Meg Smith, Chief Executive Officer
Compensation*
$425,000
Chair of the Board
Henry F. McCance
Chair's Profession / Business Affiliation
Chairman Emeritus, Greylock Partners
Board Size
7
Paid Staff Size
32
*2023 compensation, as reported by the organization, includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Note: For the year ended December 31, 2022, Katharine Herman, Execuitve Vice President for Development, was the highest paid staff member receiving compensation of $355,003.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Direct mail appeals, Radio, Special events, Foundation grants, Corporate solicitation
Fundraising costs were 5% of related contributions. (Related contributions, which totaled $32,071,318, are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c)(3) of the Internal Revenue Code. It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on Cure Alzheimer's Fund's audited financial statements for the year ended December 31, 2022.
Source of Funds
| Contributions | $26,122,432 |
| Donated stock | $5,919,199 |
| Special events, net | $306,887 |
| Investment income, net | $8,492,261 |
| Total Income | $40,840,779 |
Programs: 91% Fundraising: 5% Administrative: 3%
| Total Income | $40,840,779 |
| Total expenses: | $30,582,670 |
| Program expenses | $27,887,116 |
| Fundraising expenses | $1,662,785 |
| Administrative expenses | $1,033,769 |
| Other expenses | $0 |
| Income in Excess of Expenses | $10,258,109 |
| Beginning Net Assets | $18,200,501 |
| Other Changes In Net Assets | $0 |
| Ending Net Assets | $28,458,610 |
| Total Liabilities | $1,734,174 |
| Total Assets | $30,192,784 |
An organization may change its practices at any time without notice. A copy of this report has been shared with the organization prior to publication. It is not intended to recommend or deprecate, and is furnished solely to assist you in exercising your own judgment. If the report is about a charity and states the charity meets or does not meet the Standards for Charity Accountability, it reflects the results of an evaluation of information and materials provided voluntarily by the charity. The name Better Business Bureau is a registered service mark of the International Association of Better Business Bureaus.
This report is not to be used for fundraising or promotional purposes.
RELATED CONTENT
-
Meets Standards
-
Standards Not Met
-
Did Not Disclose
-
Review in Progress
-
Unable to Verify
Report completed by:
BBB Wise Giving Alliance